Applied DNA Sciences Inc (NAS:APDN)
$ 3.74 0.005 (0.13%) Market Cap: 3.23 Mil Enterprise Value: 982,000.00 PE Ratio: 0 PB Ratio: 0.61 GF Score: 50/100

Q2 2023 Applied DNA Sciences Inc Earnings Call Transcript

May 11, 2023 / 08:30PM GMT
Release Date Price: $21.6 (-0.92%)
Operator

Hello and welcome to the Applied DNA Sciences' fiscal second quarter 2023 financial results. All parties will be in listen-only mode. (Operator Instructions) Please note today's event is being recorded. And now I'd like to turn the conference over to Sanjay Hurry, Head of Investor Relations. Please, go ahead.

Sanjay Hurry
Applied DNA Sciences Inc. - Head of Investor Relations

Thank you, Keith. Good afternoon, everyone, and welcome to Applied DNA's conference call to discuss our second quarter fiscal 2023 financial results. You can access the press release that was issued after market close today as well as a slide presentation accompanying this call on the Investor Relations section of our corporate website.

Speaking on the call today are Dr. James Hayward, our Chairman, President and CEO, and Beth Jantzen, our CFO. Clay Shorrock, our Chief Legal Officer and Head of Business Development, will also be available to answer questions on the Q&A portion of this call.

Before we begin, please note that some of the information you will hear

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot